This website is part of the ECDC (European Centre for Disease Prevention and Control) network

Guidance on antivirals


The 2009 influenza A (H1N1) pandemic site is no longer being updated. However, updated pandemic 2009 evaluations are available on the influenza pandemic preparedness site, together with the summaries of the pandemic.


The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza. For updated information, see the seasonal influenza site. For information regarding pandemic preparedness, including post-pandemic plans, see the influenza pandemic preparedness site.

On specific request from Member States or the European Commission, ECDC convenes scientific panels to provide guidance for policymakers in the area of public health. These panels analyse the available evidence on a particular question in order to help European Union (EU) Member States to make policy choices. They highlight the issues that need to be considered and provide a list of policy options for each of these.

ECDC interim guidance on public health use of influenza antivirals during influenza pandemics  (August 2009)

On public health use of influenza antivirals during influenza pandemics (with particular reference to the pandemic (H1N1) 2009)
This document is a summary of an ECDC Interim Guidance called, “public health use of influenza antivirals during influenza pandemics”.

WHO evidence-based guidelines for use of influenza antivirals (H1N1) World Health Organisation (Geneva)  
On the 21 August 2009, WHO issued evidence-based guidelines for the use of influenza antivirals.











© European Centre for Disease Prevention and Control (ECDC) 2005 - 2017